AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Abivax SA American Depositary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01JLQNZV9
88.01▼ 2.22 (-2.46%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
90.23
Day's Range
87.03 – 89.60
52-Week Range
69.81 – 148.83
Volume
425.7K
Avg Volume
1.3M
Share Statistics
Shares Outstanding
Employees
69
Exchange
XNAS
Listed
2023-10-20
Share count as of December 31, 2025

Abivax SA American Depositary Shares (ABVX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Abivax SA American Depositary Shares (ABVX)
What is Abivax SA American Depositary Shares's Market Cap?
Abivax SA American Depositary Shares's Market Cap is $6.9B, based on as-reported figures from SEC (XBRL) filings.
What is Abivax SA American Depositary Shares's Enterprise Value?
Abivax SA American Depositary Shares's Enterprise Value is $6.5B, based on as-reported figures from SEC (XBRL) filings.
What is Abivax SA American Depositary Shares's Net Income (TTM)?
Abivax SA American Depositary Shares's Net Income (TTM) is -$465.2M, based on as-reported figures from SEC (XBRL) filings.
What is Abivax SA American Depositary Shares's Diluted EPS (TTM)?
Abivax SA American Depositary Shares's Diluted EPS (TTM) is -5.92, based on as-reported figures from SEC (XBRL) filings.
What is Abivax SA American Depositary Shares's Net Debt?
Abivax SA American Depositary Shares's Net Debt is -$443.0M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ABVXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of EUR, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025
Profit or loss [abstract]
Other operating income
Total operating income
Sales and marketing
Research and development
General and administrative
Total operating expenses
Operating loss
Financial expenses
Financial income
Financial gain (loss)
Net loss before tax
Net loss for the period